Teleflex updates on OEM and Acute Care divestitures; FTC Second Request for urology deal

TELEFLEX INC

OEM HSR waiting period expired March 13, 2026; closing anticipated in Q3 2026.
Acute Care and Urology deal received FTC Second Request on March 11, extending HSR review.
Company and Intersurgical cooperating with FTC; close expected in H2 2026.
Both transactions, announced Dec 9, 2025, are separate and subject to other conditions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.